Viewing posts categorised under: Phase-i-trials

Things to Remember When Planning Your Phase I Oncology Study

Oncology trials are complex, especially first-in-human phase I trials. You are full of optimism, while at the same time anxious about all of the unknowns. Important questions about the drug’s safety profile, pharmacokinetics, and dose need to be answered. As you start planning for the phase 1 study, you may quickly realize how much more […]

Dr. Dan Von Hoff honored at Governor’s Celebration

Our colleague Dan Von Hoff, M.D., a founder and shareholder of Medelis and the chairman of our medical advisory board, was recently named Arizona’s ‘Community Service Leader of the Year’ at the 2008 Governor’s Celebration of Innovation in Phoenix. Dr. Von Hoff is a world-renowned cancer researcher and member of the National Institute of Health’s National Cancer Advisory Board, has devoted more than 35 years to two primary goals: identifying the best new anti-cancer agents to treat patients and curing pancreatic cancer. He has published more than 540 scientific papers, more than 130 book chapters, and nearly 950 scientific abstracts. He holds a dozen patents for new anti-cancer agents and medical devices.